Upgrade to SI Premium - Free Trial

Mylan (MYL) Announces Launch of Generic Cancidas for Injection

October 2, 2017 12:40 PM
Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Caspofungin Acetate for Injection, one of the first generic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News

Next Articles